A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/315 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2340556
A new use of a zinc tranexamate compound in the treatment of diabetes is disclosed. Oral administration of the compound adequately slows down absorption of glucose from digestive tracts by inhibiting .alpha.-glucosidase in vivo. The zinc tranexamate compound is also effective in the treatment of insulin-resistant type II diabetes.
Fujimura Hajime
Natsuki Reiko
Nozaki Masakatsu
Tanaka Shun-Ichi
Hamari Chemicals Ltd.
Ridout & Maybee Llp
LandOfFree
Use of zinc tranexamate in the treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of zinc tranexamate in the treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of zinc tranexamate in the treatment of diabetes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1400717